Daria studied the plague bacterium now alleged to have killed her

The Irkutsk laboratory employee reported to have died from plague was a co-author of research on the very bacterium alleged to have caused her death.

That connection is documented in the published programme of a Russian infectious-disease congress held earlier this year. Daria Shipilova is identified in reporting on the case; the scientific record lists Shipilova D.N. among the authors of a presentation examining how Siberian Yersinia pestis strains respond to antibiotics. ^{[1] [3]}

The diagnosis remains disputed. Russian media reports have linked her death to plague, while Rospotrebnadzor, Russia's public-health watchdog, says she had pneumonia of undetermined cause and that testing did not detect microorganisms associated with her work. ^{[3] [4]}

A name in the conference programme

The XVIII All-Russian Congress on Infectious Diseases programme scheduled the presentation for 31 March 2026, in a session on naturally occurring and zoonotic infections.

Its title translates as “Study of the susceptibility of Yersinia pestis from natural plague foci in Siberia to antibacterial drugs.” The listed presenter was Svetlana Vityazeva, of the Irkutsk Anti-Plague Research Institute. Shipilova appears among six additional authors. Being listed as a co-author does not establish that she personally delivered the presentation. ^[1]

Her presence in that author list matters because it connects her to a specific research project involving the organism, beyond the fact that she worked at an anti-plague institute. The programme does not describe individual contributions or her duties immediately before she became ill.

The result that needs explaining

The accompanying abstract, on printed page 28 of the proceedings, concerns strains from the Gorno-Altai highland and Tuva mountain plague foci. It describes three testing approaches: ^[2]

These are method-specific counts. The abstract does not establish 244 distinct strains or give a strain-by-strain account of the anomalous readings.

The unusual readings concerned minimum inhibitory concentrations, or MICs: measurements of the amount of antibiotic needed to inhibit visible bacterial growth in a laboratory test.

Crucially, the authors' overall conclusion was that the strains were highly susceptible to the selected antibiotics. They called for further investigation before using the commercial strips. The discrepancy therefore does not establish multidrug-resistant plague. ^[2]

Why the antibiotics matter

Two of the drugs named in the anomalous results, ciprofloxacin and streptomycin, feature in US Centers for Disease Control and Prevention guidance for treating pneumonic or septicemic plague. Reliable susceptibility measurements consequently have a practical clinical purpose. ^[5]

But laboratory susceptibility and a patient's outcome are different questions. The CDC stresses starting appropriate treatment promptly when plague is suspected, without waiting for confirmatory test results. A death, by itself, would not demonstrate that antibiotics had failed because of resistance. ^[5]

The abstract supplies no account of Shipilova's illness or treatment. It predates those events by months.

The missing link is the clinical evidence

Reporting by Siberia.Realities, republished by Crimea.Realities, describes allegations of a laboratory accident and interviews with former colleagues and classmates. Those allegations remain unverified. In its statement published on 4 October, Rospotrebnadzor said its investigation had found no accidents involving pathogenic microorganisms at the institute. ^{[3] [4]}

Establishing a connection between the research and her death would require evidence beyond authorship: identification of the organism responsible for her illness, any relevant isolate and its susceptibility results, and a documented account of possible exposure.

Those are the records needed to evaluate whether a research strain was involved and whether resistance contributed. The conference abstract establishes her participation in plague research; the clinical and exposure evidence must establish what happened to her.